E-LIB Suche - Ergebnisse für: Murciano-Goroff, Yonina R

1

Basket Trials: Past, Present, and Future:

Murciano-Goroff, Yonina R. ; Uppal, Manik ; Chen, Monica..
Annual Review of Cancer Biology. 8 (2024) 1 - p. 59-80 , 2024

Link: https://doi.org/10.1146/..

2

Neoplasia risk in patients with Lynch syndrome treated with..:

Harrold, Emily C. ; Foote, Michael B. ; Rousseau, Benoit...
Nature Medicine. 29 (2023) 10 - p. 2458-2463 , 2023

Link: https://doi.org/10.1038/..

3

In Reply to "Selpercatinib Controls Central Nervous System ..:

Murciano-Goroff, Yonina R. ; Lin, Sabrina T. ; Wilhelm, Clare..
Journal of Thoracic Oncology. 18 (2023) 5 - p. e52-e53 , 2023

Link: https://doi.org/10.1016/..

4

Central Nervous System Disease in Patients With RET Fusion-..:

Murciano-Goroff, Yonina R. ; Falcon, Christina J. ; Lin, Sabrina T....
Journal of Thoracic Oncology. 18 (2023) 5 - p. 620-627 , 2023

Link: https://doi.org/10.1016/..

5

Precision Oncology: 2023 in Review:

Murciano-Goroff, Yonina R. ; Suehnholz, Sarah P. ; Drilon, Alexander.
Cancer Discovery. 13 (2023) 12 - p. 2525-2531 , 2023

Link: https://doi.org/10.1158/..

6

Case Report: Complete pathologic response to neoadjuvant se..:

Goldman, Jonathan W. ; Sholl, Lynette M. ; Dacic, Sanja...
Frontiers in Oncology. 13 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

7

Comprehensive analysis of germline drivers in endometrial c..:

Gordhandas, Sushmita ; Rios-Doria, Eric ; Cadoo, Karen A...
JNCI: Journal of the National Cancer Institute. 115 (2023) 5 - p. 560-569 , 2023

Link: https://doi.org/10.1093/..

8

ctDNA-based detection of molecular residual disease in stag..:

Lebow, Emily S. ; Shaverdian, Narek ; Eichholz, Jordan E....
Frontiers in Oncology. 13 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

9

The KRYSTAL-1 study of adagrasib — a new trial for KRASG12C..:

Murciano-Goroff, Yonina R. ; Lito, Piro
Nature Reviews Clinical Oncology. 19 (2022) 11 - p. 677-678 , 2022

Link: https://doi.org/10.1038/..

10

Molecular Characterization of Acquired Resistance to KRASG1..:

Yaeger, Rona ; Mezzadra, Riccardo ; Sinopoli, Jenna...
Cancer Discovery. 13 (2022) 1 - p. 41-55 , 2022

Link: https://doi.org/10.1158/..

11

Reversion mutations in germline BRCA1/2-mutant tumors revea..:

Murciano-Goroff, Yonina R. ; Schram, Alison M. ; Rosen, Ezra Y....
Nature Communications. 13 (2022) 1 - p. , 2022

Link: https://doi.org/10.1038/..

12

A phase II Study of TAS-117 in Patients with Advanced Solid..:

Rodón, Jordi ; Funchain, Pauline ; Laetsch, Theodore W...
Future Oncology. 18 (2022) 30 - p. 3377-3387 , 2022

Link: https://doi.org/10.2217/..

13

Overall survival with circulating tumor DNA-guided therapy ..:

Jee, Justin ; Lebow, Emily S. ; Yeh, Randy...
Nature Medicine. 28 (2022) 11 - p. 2353-2363 , 2022

Link: https://doi.org/10.1038/..

14

Diverse alterations associated with resistance to KRAS(G12C..:

Zhao, Yulei ; Murciano-Goroff, Yonina R. ; Xue, Jenny Y....
Nature. 599 (2021) 7886 - p. 679-683 , 2021

Link: https://doi.org/10.1038/..

15

Temporal Trends and Outcomes Among Patients Admitted for Im..:

Molina, Gabriel E. ; Zubiri, Leyre ; Cohen, Justine V....
The Oncologist. 26 (2021) 6 - p. 514-522 , 2021

Link: https://doi.org/10.1002/..